University of Las Palmas de Gran Canaria
Also known as: Canarias University | Canarias University Hospital | COMPLEJO HOSPITALARIO UNIVERSITARIO DE CANARIAS | Complejo Hospitalario Universitario Insular Materno Infantil | Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas, Spain | Dr. Negrín University Hospital, Las Palmas, Spain | Gutiérrez-Hernández, ME | Hospital Insular de las Palmas | Hospital La Paloma Las Palmas de Gran Canaria | Hospital Univer. Materno-Infantil de Canarias ( Las Palmas de Gran Canaria) | Hospital Universitario de Canarias | Hospital Universitario de Canarias. La Laguna | Hospital Universitario de Canarias. La Laguna. Tenerife. Spain | Hospital Universitario de Gran Canaria | Hospital Universitario Insular de Canarias | Hospital Universitario Materno-Infantil de Canarias, Las Palmas de Gran Canaria | Hosptial Dr. Negrin de Las Palmas de Gran Canaria | Institute for Applied Microelectronics, University of Las Palmas de G. C., Spain | Las Palmas Medical Center | University of Las Palmas de G. C. | University of Las Palmas de Gran Canaria
Highest phase reached
Phase 4
First clinical trial
May 1, 2007Last known activity
May 28, 2021
Timeline
1960s
- Jun 1, 1965
University of Las Palmas de Gran Canaria— Founded
Drugs by trial phase (42 distinct, 29 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Aggression
- Anemia
- Breast Neoplasms
- Chondrosarcoma
- Colorectal Neoplasms
- Coronary Artery Disease
- Edema
- Fibrosis
- Heart Diseases
- Heart Failure
- Infarction
- Irritable Bowel Syndrome
- Ischemia
- Kidney Failure, Chronic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Macular Degeneration
- Macular Edema
- Metabolic Syndrome
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms, Fibrous Tissue
- Neuralgia
- Peripheral Nervous System Diseases
- Prostatic Neoplasms
- Renal Insufficiency
- Solitary Fibrous Tumors
- ST Elevation Myocardial Infarction
- Syndrome
- Wet Macular Degeneration
Recent trials (41)
- NCT05131386Overall official - principal investigatorPhase 2May 28, 2021
- NCT04299893Overall official - principal investigatorPhase 2/Phase 3Mar 31, 2020
- NCT04299893Overall official - principal investigatorPhase 2/Phase 3Mar 31, 2020
- NCT04299893Study chairPhase 2/Phase 3Mar 31, 2020
- NCT03937505Overall official - principal investigatorPhase 2May 31, 2019
- NCT03830489Overall official - principal investigatorPhase 4Feb 28, 2019
- NCT03830489Lead sponsorPhase 4Feb 28, 2019
- NCT03660657Overall official - principal investigatorPhase 2/Phase 3Oct 31, 2018
- NCT03660657Study chairPhase 2/Phase 3Oct 31, 2018
- NCT03699215Lead sponsorPhase 3Oct 1, 2018
- NCT03247452Lead sponsorN/ADec 18, 2017
- NCT03247452Study directorN/ADec 18, 2017
- NCT03196388CollaboratorPhase 2Jun 1, 2017
- NCT03073408Sponsor investigatorN/AMar 6, 2017
- NCT02066285Study directorPhase 2Jun 1, 2014
Details
- Founded
- Las Palmas de G.C., ES Jun 1, 1965
- Last known activity
- May 28, 2021
Notes
--- Pre-folding founded info: None None None None None ---